Benabente, Helfseth P.

HRN: 28-96-96  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/11/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/11/2026
05/18/2026
IV
4.5g
Q 6 Hours
Hepatic Pathology
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines